JNJ:NYE-Johnson & Johnson

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing

USD 140.23

Change

+0.79 (+0.57)%

Market Cap

USD 306.11B

Volume

7.12M

Analyst Target

USD 148.12
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-18 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
SSO ProShares Ultra S&P500

+2.46 (+1.93%)

USD 2.40B
QLD ProShares Ultra QQQ

+2.44 (+2.47%)

USD 1.90B
UYG ProShares Ultra Financials

+0.95 (+2.06%)

USD 0.80B
PSQ ProShares Short QQQ

-0.34 (-1.24%)

USD 0.50B
DDM ProShares Ultra Dow30

+0.90 (+1.84%)

USD 0.36B
DOG ProShares Short Dow30

-0.47 (-0.89%)

USD 0.22B
UWM ProShares Ultra Russell2000

+1.51 (+2.40%)

USD 0.17B
DXD ProShares UltraShort Dow30

-0.47 (-1.82%)

USD 0.16B
MVV ProShares Ultra MidCap400

+0.61 (+1.57%)

USD 0.14B
URE ProShares Ultra Real Estate

+0.18 (+0.21%)

USD 0.14B

ETFs Containing JNJ

ZUQ:CA BMO MSCI USA High Quality.. 0.00 % 0.32 %

+0.21 (+1.21%)

CAD 0.26B
ZSP:CA BMO S&P 500 Index ETF.. 0.00 % 0.09 %

+0.39 (+1.21%)

CAD 6.06B
ZSP.U:CA 0.00 % 0.09 %

N/A

N/A
HBF:CA Harvest Brand Leaders Plu.. 0.00 % 1.16 %

+0.04 (+1.21%)

CAD 0.14B
MULC:CA Manulife Multifactor U.S... 0.00 % 0.45 %

N/A

CAD 8.90M
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.89 %

N/A

CAD 0.01B
MULC.B:CA 0.00 % 0.39 %

N/A

N/A
HBF.U:CA 0.00 % 1.15 %

N/A

N/A
ZGQ:CA BMO MSCI All Country Worl.. 0.00 % 0.50 %

+0.10 (+1.21%)

CAD 0.07B
XWD:CA iShares MSCI World Index .. 0.00 % 0.47 %

+0.37 (+1.21%)

CAD 0.80B
XMY:CA iShares Edge MSCI Min Vol.. 0.00 % 0.48 %

-0.04 (1.21%)

CAD 0.02B
XMW:CA iShares Edge MSCI Min Vol.. 0.00 % 0.48 %

+0.01 (+1.21%)

CAD 0.19B
XHU:CA iShares U.S. High Dividen.. 0.00 % 0.33 %

N/A

CAD 0.08B
XSP:CA iShares Core S&P 500 .. 0.00 % 0.11 %

+0.29 (+1.21%)

CAD 4.69B
XUH:CA iShares Core S&P U.S... 0.00 % 0.07 %

+0.05 (+1.21%)

CAD 0.08B
XUU:CA iShares Core S&P U.S... 0.00 % 0.07 %

+0.24 (+1.21%)

CAD 1.48B
XUS:CA iShares Core S&P 500 .. 0.00 % 0.11 %

+0.42 (+1.21%)

CAD 1.82B
XDU:CA iShares Core MSCI US Qual.. 0.00 % 0.16 %

+0.02 (+1.21%)

CAD 0.06B
XDUH:CA iShares Core MSCI US Qual.. 0.00 % 0.15 %

N/A

CAD 0.01B
FCRR:CA Fidelity U.S. Dividend fo.. 0.00 % 0.39 %

+0.23 (+1.21%)

CAD 0.06B
NTSX WisdomTree 90/60 U.S. Bal.. 0.00 % 0.00 %

+0.14 (+1.21%)

USD 5.43M
QARP DBX ETF Trust - Xtrackers.. 0.00 % 0.19 %

+0.22 (+1.21%)

USD 0.14B
DRMU:CA Desjardins RI USA - Low C.. 0.00 % 0.29 %

N/A

CAD 6.11M
FLAM:CA Franklin FTSE U.S. Index .. 0.00 % 0.00 %

N/A

CAD 0.28B
SFY SoFi Select 500 ETF 0.00 % 0.00 %

+0.13 (+1.21%)

USD 0.05B
XSUS:CA iShares ESG MSCI USA Inde.. 0.00 % 0.00 %

N/A

CAD 4.07M
QUU:CA Mackenzie US Large Cap Eq.. 0.00 % 0.09 %

+0.77 (+1.21%)

CAD 0.19B
VSMV VictoryShares US Multi-Fa.. 0.00 % 0.35 %

+0.05 (+1.21%)

USD 0.04B
XMX WisdomTree Global ex-Mexi.. 0.00 % 0.26 %

+0.31 (+1.21%)

USD 3.00M
WEXP 0.00 % 0.33 %

N/A

N/A
LIFE aTyr Pharma, Inc 0.00 % 0.69 %

+0.09 (+1.21%)

USD 0.02B
SCHK Schwab 1000 ETF 0.00 % 0.05 %

+0.29 (+1.21%)

USD 0.83B
AIEQ AI Powered Equity ETF 0.00 % 0.75 %

+0.23 (+1.21%)

USD 0.12B
ESGU iShares MSCI USA ESG Opti.. 0.00 % 0.15 %

+0.68 (+1.21%)

USD 0.25B
DMRL DeltaShares S&P 500 Manag.. 0.00 % 0.35 %

+0.40 (+1.21%)

USD 0.42B
XHD:CA iShares U.S. High Dividen.. 0.00 % 0.33 %

+0.06 (+1.21%)

CAD 0.21B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.68 (+1.21%)

CAD 0.29B
PEU:CA Purpose Enhanced US Equit.. 0.00 % 1.43 %

N/A

CAD 2.73M
PEU.B:CA 0.00 % 1.16 %

N/A

N/A
OVLC 0.00 % 0.30 %

N/A

N/A
PHDG Invesco S&P 500 Downside .. 0.00 % 0.38 %

+0.08 (+1.21%)

USD 0.04B
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+1.44 (+1.21%)

USD 0.01B
RUD.U:CA 0.00 % 0.43 %

N/A

N/A
ROLA 0.00 % 0.00 %

N/A

N/A
ONEK 0.00 % 0.10 %

N/A

N/A
LOWC SPDR MSCI ACWI Low Carbon.. 0.00 % 0.20 %

+0.90 (+1.21%)

USD 0.07B
CRBN iShares MSCI ACWI Low Car.. 0.00 % 0.20 %

+1.21 (+1.21%)

USD 0.45B
BWV 0.00 % 0.75 %

N/A

N/A
AOR iShares Core Growth Alloc.. 0.00 % 0.18 %

+0.18 (+1.21%)

USD 1.32B
GHS 0.00 % 0.48 %

N/A

N/A
HUSV First Trust Horizon Manag.. 0.00 % 0.70 %

+0.10 (+1.21%)

USD 0.22B
IVW iShares S&P 500 Growth ET.. 0.00 % 0.18 %

+1.73 (+1.21%)

USD 23.46B
IUSG iShares Core S&P U.S. Gro.. 0.00 % 0.04 %

+0.63 (+1.21%)

USD 6.66B
RUD:CA RBC Quant U.S. Dividend L.. 0.00 % 0.43 %

N/A

CAD 0.39B
SCHB Schwab U.S. Broad Market .. 0.00 % 0.03 %

+0.73 (+1.21%)

USD 15.36B
URTH iShares MSCI World ETF 0.00 % 0.24 %

+0.92 (+1.21%)

USD 0.63B
TPU:CA TD U.S. Equity Index ETF 0.00 % 0.11 %

+0.12 (+1.21%)

CAD 0.03B
TOK iShares MSCI Kokusai ETF 0.00 % 0.25 %

+0.67 (+1.21%)

USD 0.14B
USWD 0.00 % 0.33 %

N/A

N/A
VIXH 0.00 % 0.60 %

N/A

N/A
XAW:CA iShares Core MSCI All Cou.. 0.00 % 0.22 %

+0.20 (+1.21%)

CAD 1.01B
VOOG Vanguard S&P 500 Growth I.. 0.00 % 0.15 %

+1.60 (+1.21%)

USD 2.74B
THRK 0.00 % 0.10 %

N/A

N/A
TILT FlexShares Morningstar US.. 0.00 % 0.25 %

+1.15 (+1.21%)

USD 1.24B
SHU:CA 0.00 % 0.70 %

N/A

N/A
SFLA 0.00 % 0.00 %

N/A

N/A
SCHX Schwab U.S. Large-Cap ETF 0.00 % 0.03 %

+0.65 (+1.21%)

USD 16.99B
SICK 0.00 % 0.95 %

N/A

N/A
SPLX 0.00 % 0.00 %

N/A

N/A
SYG SPDR MFS Systematic Growt.. 0.00 % 0.61 %

+0.82 (+1.21%)

USD 0.03B
SPYG SPDR Portfolio S&P 500 Gr.. 0.00 % 0.06 %

+0.41 (+1.21%)

USD 5.43B
AOA iShares Core Aggressive A.. 0.00 % 0.18 %

+0.40 (+1.21%)

USD 0.95B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.66% 65% D 43% F
Dividend Return 1.43% 45% F 47% F
Total Return 10.10% 65% D 42% F
Trailing 12 Months  
Capital Gain 15.59% 67% D+ 89% B+
Dividend Return 3.01% 42% F 49% F
Total Return 18.60% 67% D+ 88% B+
Trailing 5 Years  
Capital Gain 36.40% 71% C- 78% C+
Dividend Return 15.77% 53% F 55% F
Total Return 52.16% 71% C- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 7.55% 76% C 76% C
Dividend Return 10.38% 76% C 77% C+
Total Return 2.82% 67% D+ 55% F
Risk Return Profile  
Volatility (Standard Deviation) 10.67% 90% A- 64% D
Risk Adjusted Return 97.29% 90% A- 86% B
Market Capitalization 306.11B 100% A+ 100% A+

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.64 30% F 25% F
Price/Book Ratio 6.25 23% F 11% F
Price / Cash Flow Ratio 4.31 22% F 29% F
Price/Free Cash Flow Ratio 24.09 30% F 22% F
Management Effectiveness  
Return on Equity 31.35% 89% B+ 91% A-
Return on Invested Capital 27.40% 93% A 90% A-
Return on Assets 12.65% 89% B+ 92% A-
Debt to Equity Ratio 37.50% 69% D+ 73% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.